James Breitmeyer | President & Chief Executive Officer |
Richard Vincent | Chief Financial Officer |
Salim Yazji | Chief Medical Officer |
Hartaj Singh | Oppenheimer |
Carl Byrnes | Northland Capital Markets |
Brian Petitt | BTIG Investment Banking |
Shubhendu Sen Roy | Brookline Capital Markets |
Greetings and welcome to Oncternal Therapeutics, Inc Third Quarter 2022 Financial Results Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] It is now my pleasure to introduce your host, Richard Vincent, Chief Financial Officer. Thank you.